News Bulletin
Monday Oct 15, 2018
Evening Edition

 

 

Economic Numbers

 

 

TIME

DETAIL

SURV

PRIOR

 

08:30


Core Retail Sales (MoM) (Sep)

-0.1%

0.2%

 

08:30

Retail Sales (MoM) (Sep)

0.1%

0.1%

 

-

-

-

-

 

-

-

-

-

 

-

-

-

 

-

-

-

-

 

-

-  

-

-

 

 

 

Indices

 

 

CLOSE

50 DMA

200 DMA

S&P 500

2,759.82

-

-

DJIA

25,245.30

-

-

NASDAQ

7,430.12

-

-

 

15th Oct, 2018 Market News

 

08:36 Tandem Diabetes Care [TNDM] is up +6% premarket on modest volume following Health Canada's nod for its t:slim X2 Insulin Pump.

 

08:51 Shares of Nutrisystem [NTRI] (-7%) are down sharply in early trading after DA Davidson downgrades to Underperform from Neutral. The firm warns of a cut in Nutrisystem's full-year guidance when Q3 earnings are released.

 

08:55 Inovio Pharmaceuticals [INO] is up +7% premarket on light volume on the heels of its announcement of positive preclinical data on its Ebola vaccine INO-4212.

 

09:03 Ultra-thinly traded nano cap XTL Biopharmaceuticals [XTLB] (+28%) is the latest tiny biotech to rally, up 28% premarket on average volume, albeit on turnover of only 5,700 shares.

 

08:51 Sibanye-Stillwater [SBGL] +6.8% pre-market and surging as much as 20% on the Johannesburg Stock Exchange, a development the company says is reflective of its “better outlook." “We are recovering from the significant negativity from the first quarter and the market is starting to reflect the better outlook,” says SBGL's head of investor relations.

 

10:22 Shares of Manchester United [MANU] are up +2.92% after The Sunreports that Saudi Arabia Crown Prince Mohammad bin Salman want to make what's called by the daily publication as a "massive" investment in the soccer club.

 

10:29 Thinly traded nano cap Aevi Genomic Medicine [GNMX] (+1.9%) is up on below-average volume following its announcement that Part B of its Phase 2 ASCEND study evaluating AEVI-001 in pediatric and adolescent patients with attention deficit hyperactivity disorder (ADHD) is now fully enrolled.

 

11:00 Thinly traded micro cap Anixa Biosciences [ANIX] (+4%) is up on below-average volume in response to its announcement that it has filed an application with the FDA requesting a in-person meeting to clarify a regulatory path for Cchek

, an artificial intelligence (AI)-based cancer detection technology, as a test for prostate cancer.

 

11:10 Raymond James downgrades ARRIS [ARRS] (-3.9%) from Strong Buy to Outperform and cuts the target from $36 to $29, a 25% upside to Friday’s close.

 

11:13 Nano cap SELLAS Life Sciences Group [SLS] (+18.4%) is up more than a 4x surge in volume following its announcement that it will host a conference call on Monday, October 22, at 8:00 am ET to discuss updated and final results from its Phase 2b clinical trial evaluating NeuVax (nelipepimut-S) plus Roche's (OTCQX:RHHBY +0.2%) Herceptin (trastuzumab) in HER2 low-expressing breast cancer patients. The call will follow the presentation of the data at ESMO in Munich.

 

11:27 Puma Biotechnology [PBYI] (-5%) is down on below-average volume in apparent reaction to Roche's (OTCQX:RHHBY +0.2%) announcement of positive late-stage data on Kadcyla (ado-trastuzumab) as adjuvant treatment in patients with early-stage HER2-positive breast cancer. Puma's Nerlynx (neratinib) was OK'd in the U.S. in July 2017 for the same indication.

 

11:32 Occidental Petroleum [OXY] (-4.2%) plunges after Qatar Petroleum says it will take over management and operation of the Idd El-Shargi North Dome offshore oilfield upon next year's expiration of the 1994 production sharing agreement.

 

13:05 Ultra-thinly traded nano cap Presbia PLC [LENS] (-17.9%) is down on almost a 10x surge in volume, albeit on turnover of only 80K shares, adding to the down move that started last week after the company disclosed that the expected FDA nod for its Flexivue Microlens may not happen for another year. Shares have slumped almost 40% since then.

 

13:54 Nano cap Valeritas Holdings [VLRX] (-11.8%) is down on almost double normal volume on the heels of its preliminary prospectus for a $50M stock offering, specifically, ~38M shares at an assumed price of $1.33.

 

14:19 General Electric [GE] (-0.9%) ticks lower as Cowen analyst Gautam Khanna cuts his stock price target to $12 from $14.50 while maintaining a Market Perform rating, expecting new CEO Larry Culp will impose a dividend cut and perhaps raise more equity to shore up the balance sheet.

 

14:22 Kansas City Southern [KSU] tracks up +2.66% after an upgrade from Deutsche Bank captures some attention. The DB note indicates that the firm sees the sell-off in the railroad stock as a little overdone. "Post sell-off we now view shares as highly attractive in light of growth prospects," writes the analyst team.


For internal use only.